Cargando…

Rheumatic diseases in women and children : current perspectives /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Sharma, Shefali K., Sawhney, Sujata
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New Delhi ; Philadelphia : Jaypee Brothers Medical Publishers, [2014]
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Machine generated contents note: SECTION 1 WOMEN ISSUES IN RHEUMATIC DISEASES
  • 1. Rheumatoid Arthritis and Pregnancy / Anil Abrol
  • Fertility in Rheumatoid Arthritis
  • Effects of Pregnancy on Rheumatoid Arthritis
  • Possible Mechanisms of Effects on Disease Activity
  • Pregnancy Outcomes in Rheumatoid Arthritis
  • 2. Pregnancy and SLE / Amita Aggarwal
  • Immunologic Changes in Pregnancy
  • Effect of Pregnancy on SLE
  • Effect of SLE on Pregnancy
  • Management of SLE and Pregnancy
  • Management of Pregnancy with Anti-Ro/La Positivity
  • Management of Pregnancy with APS
  • Long-term Consequences of Lupus Pregnancy
  • 3. Lupus Nephritis and Pregnancy / Manish Rathi
  • Is Pregnancy Possible in Patients with Lupus Nephritis?
  • What is the Most Preferred Time for Pregnancy?
  • What if Patient with LN Decides to get Pregnant?
  • Long-term Outcome of Pregnant LN Patients
  • 4. Pregnancy in Systemic Sclerosis / Shefali K Sharma
  • Fertility in Systemic Sclerosis
  • Pregnancy Outcomes
  • Prematurity
  • Effects of Pregnancy on Systemic Sclerosis
  • Management of Pregnancy
  • Management of Delivery
  • 5. Antiphospholipid Syndrome in Pregnancy / Varun Dhir
  • Pathogenesis of Antiphospholipid Syndrome
  • Diagnosis of APS and Criteria of Classification
  • Laboratory Findings in APS
  • Treatment of Antiphospholipid Syndrome in Pregnancy
  • 6. Systemic Vasculitis and Pregnancy / Vinod Ravindran
  • Fertility
  • Conception
  • Pregnancy
  • Postpartum Period
  • Pharmacotherapy Relevant to Pregnancy and Lactation
  • 7. Antirheumatic Drugs in Pregnancy / Shefali K Sharma
  • Minimal Maternal and Fetal Risk
  • Selective Use Allowed During Pregnancy
  • Moderate to High Risk of Fetal Harm
  • Unknown Risk
  • 8. Use of Antirheumatic Drugs During Lactation / Vinod KV
  • Drugs Safe to be Used During Lactation
  • Potentially Safe Drugs that Can be Used During Lactation
  • Drugs to be Avoided During Lactation
  • 9. Risk of Children Born to Mothers with Rheumatic Diseases / Surjit Singh
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Systemic Lupus Erythematosus
  • Systemic Sclerosis
  • Fetal Outcome and Rheumatic Diseases
  • Anti-Ro (SSA) and Anti-La (SSB) Antibodies
  • The Neonatal Lupus Syndrome
  • Commonly used Immunosuppresive Medications in Rheumatology and Risks thereof to the Fetus
  • SECTION 2 PEDIATRIC RHEUMATOLOGY
  • 10. Iuvenile Idiopathic Arthritis / Athimalaipet V Ramanan
  • Clinical Vignette
  • Classification
  • Clinical Features
  • Etiology and Pathogenesis
  • 11. PUO and the Pediatric Rheumatologist / Sujata Sawhney
  • Case Vignette
  • Epidemiological Data from India and Abroad
  • Clinical Approach
  • FUO
  • CEFUO
  • 12. CTDs in Pediatrics / Sharath Kumar
  • Terminologies
  • Clinical Suspicion of a CTD
  • Differential Diagnoses
  • Diagnostic Approach
  • SLE
  • Juvenile Dermatomyositis
  • Scleroderma
  • Sjogren's Syndrome
  • MCTD
  • UCTD
  • Overlap Syndrome
  • 13. Neonatal Lupus Syndrome / Mehul P Jariwala
  • Epidemiology
  • Pathogenesis
  • Clinical Presentation
  • Management
  • A Potential Prophylactic Approach
  • Prognosis
  • 14. Childhood Vasculitis / Vijay Viswanathan
  • The Case
  • Epidemiology
  • Classification
  • Pathogenesis
  • Clinical Features
  • Clinical
  • Laboratory
  • Serology
  • Radiology
  • Computerised Tomography and Ultrasonography
  • 2-D Echocardiogram
  • Histology
  • Differential Diagnoses of Primary Vasculitides
  • Treatment Strategies
  • Prognosis
  • 15. Transition of the Child with a Rheumatic Disease to the Adult Team / Sathish Kumar
  • Defining Transition
  • What are the Differences Between Transition and Transfer?
  • What are the Steps to Successful Transition?
  • Why is Transition Important for Youth with Rheumatic Diseases?
  • What are the Determinants of Successful Transition and Transfer?
  • What are the Models of Transition?
  • What Goals Should be Adopted for a Pediatric Rheumatology Transition Program?
  • What are the Factors Determining a Patient's Readiness to Transfer Care to an Adult Rheumatologist?
  • What is the Current Scenario in India?
  • Examples of Web-based Resources for Transition.